TABLE 1.
Region | BPF-WM (mL/mL) | BPF (mL/mL)* | ||||
---|---|---|---|---|---|---|
Controls | Patients | P | Effect size | P | Effect size | |
I. sup. temporal | 90 ± 26 | 77 ± 32 | 0.214 | −0.53 | 0.280 | −0.50 |
C. sup. temporal | 86 ± 24 | 74 ± 27 | 0.199 | −0.52 | 0.264 | −0.49 |
I. mid. temporal | 97 ± 28 | 80 ± 29 | 0.113 | −0.60 | 0.154 | −0.57 |
C. mid. temporal | 93 ± 24 | 78 ± 25 | 0.096 | −0.65 | 0.135 | −0.63 |
I. inf. temporal | 103 ± 29 | 80 ± 28 | 0.034 | −0.78 | 0.052 | −0.76 |
C. inf. temporal | 100 ± 26 | 91 ± 32 | 0.423 | −0.32 | 0.528 | −0.29 |
I. fusiform | 128 ± 35 | 82 ± 24 | <0.001 | −1.35 | <0.001 | −1.34 |
C. fusiform | 122 ± 32 | 97 ± 32 | 0.041 | −0.78 | 0.058 | −0.76 |
I. parahippocampus | 146 ± 38 | 84 ± 26 | <0.001 | −1.62 | <0.001 | −1.62 |
C. parahippocampus | 146 ± 42 | 103 ± 29 | 0.002 | −1.02 | 0.003 | −1.02 |
I. hippocampus | 129 ± 29 | 66 ± 31 | <0.001 | −2.20 | <0.001 | −2.22 |
C. hippocampus | 126 ± 34 | 99 ± 30 | 0.025 | −0.79 | 0.035 | −0.78 |
I. amygdala | 75 ± 17 | 51 ± 20 | 0.002 | −1.39 | 0.005 | −1.37 |
C. amygdala | 77 ± 16 | 62 ± 22 | 0.045 | −0.94 | 0.078 | −0.89 |
I. insula | 97 ± 28 | 64 ± 21 | 0.001 | −1.18 | 0.001 | −1.17 |
C. insula | 97 ± 27 | 67 ± 20 | 0.001 | −1.11 | 0.002 | −1.10 |
I. frontal | 70 ± 18 | 68 ± 23 | 0.643 | −0.16 | 0.820 | −0.11 |
C. frontal | 67 ± 17 | 64 ± 23 | 0.648 | −0.16 | 0.828 | −0.11 |
I. parietal | 65 ± 18 | 65 ± 22 | 0.914 | 0.01 | 0.890 | 0.06 |
C. parietal | 64 ± 18 | 68 ± 24 | 0.761 | 0.20 | 0.593 | 0.26 |
I. occipital | 41 ± 11 | 45 ± 13 | 0.524 | 0.39 | 0.298 | 0.51 |
R. occipital | 39 ± 8 | 47 ± 16 | 0.235 | 1.02 | 0.130 | 1.10 |
Values obtained using VND as estimate of nondisplaceable binding (10).
I. = ipsilateral to focus; sup. = superior; C. = contralateral to focus; mid. = middle; inf. = inferior.